Women with breast cancer are twice as likely to return to work after treatment if their employer makes accommodations for them, but workplace accommodation and job retention are significantly lower for low-income and minority women.
Job loss is an often overlooked side effect of undergoing breast cancer treatment, as an estimated 20% to 30% of survivors do not go back to work 3 to 18 months after diagnosis. Previous research has found that the odds of having a job to return to after treatment are significantly better for women whose employers made accommodations for them during treatment, like providing schedule flexibility around chemotherapy appointments.
However, most studies on job retention after breast cancer have examined white, middle-class women with health insurance. Research on breast cancer’s effects on low-income and minority women has been limited, but a study of Medicaid-insured breast cancer survivors in California found just 60% were working 3 years after their diagnosis.
A study recently published in Health Affairs set out to analyze the relationship between income and job retention for racial/ethnic minority and low-income women who were being treated for breast cancer in New York City. After oversampling to include more low-income and minority women, the researchers asked 319 participants about their employment status, household income, insurance type, job tenure, and other sociodemographic characteristics. The dependent variable, measured in a follow-up survey 4 months after the end of treatment, was job retention defined as having a job or being on sick or disability leave from work at that time.
The total proportion of women working at follow-up was relatively high at 81%, but income-based disparities in job retention were profound. Just 57% of the low-income women (defined as household income less than 200% of the federal poverty level) had kept their jobs, compared to 90% of middle-income and 95% of high-income women. Race was also a factor in job retention; 98% of white women kept their jobs, while only 68% of Chinese women and 73% of Korean women returned to work.
After performing multivariable analysis, the researchers found that the women had significantly lower probabilities of job retention if they were Chinese or low-income, but were 6 times more likely to return to work if they had employer-sponsored health insurance than if they had public insurance or were uninsured.
Women who had accommodating employers were more than twice as likely to return to work after treatment, but the presence of this factor also varied based on sociodemographic characteristics. Being in the low-income group and being Chinese were both associated with lower chances of having an accommodating employer. When controlling for race and ethnicity, women who spoke primarily English or had worked at their jobs for a longer time were more likely to state that their place of employment had been accommodating of their treatment.
The Americans with Disabilities Act was designed to provide job protection for employees with disabilities and illnesses like cancer, but the study authors reported that over half of the low-income women surveyed were not covered under this law because their workplace employed less than 15 people. They recommended expanding the act to include all workers by providing tax credits to small businesses that accommodate their disabled workers.
“Breast cancer survivors who do not continue to work during treatment or return to work soon after its completion are likely to suffer long-term job loss,” the authors noted. “Therefore, job protections are critical to an already vulnerable population of low-income women.”
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America
May 6th 2024CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.
Read More
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More